These findings suggested that in primary coenzyme Q10 deficiency, CoQ10 distribution in the brain may be improved by the administration of LDLR inhibitors or by interventions to stimulate the luminal activity of SR-B1 transporters [60]. This evidence concerns the gene LDLR and coenzyme Q10 deficiency.